Invited Commentary: Omics Approaches to Mechanistic,Biomarker,and Therapeutic Development for Right Ventricular Failure in Congenital Right-Sided Obstructive Lesions: A Brave New World?
Restricted accessArticle commentaryFirst published online March, 2024
Invited Commentary: Omics Approaches to Mechanistic,Biomarker,and Therapeutic Development for Right Ventricular Failure in Congenital Right-Sided Obstructive Lesions: A Brave New World?
DavidsonJAPfeiferZFrankB, et al.Metabolomic fingerprinting of infants undergoing cardiopulmonary bypass: changes in metabolic pathways and association with mortality and cardiac intensive care unit length of stay. J Am Heart Assoc. 2018;7(24):e010711. doi:10.1161/JAHA.118.010711
2.
FrankBS. Interstage single ventricle heart disease infants show dysregulation in multiple metabolic pathways. JACC Adv. 2023;2(1):100169. doi:10.1016/j.jacadv.2022.100169
3.
FrankBSKhailovaLSilveiraL, et al.Proteomic profiling identifies key differences between inter-stage infants with single ventricle heart disease and healthy controls. Transl Res. 2021;229:24-37. doi:10.1016/j.trsl.2020.10.001
4.
GarciaAMToniLSMiyanoCA, et al.Cardiac transcriptome remodeling and impaired bioenergetics in single-ventricle congenital heart disease. JACC Basic Transl Sci. 2023;8(3):258-279.
5.
SalomonJEricssonAPriceA, et al.Dysbiosis and intestinal barrier dysfunction in pediatric congenital heart disease is exacerbated following cardiopulmonary bypass. JACC Basic Transl Sci. 2021;6(4):311-327.
6.
AliEASyedAKhailovaL, et al.Novel biomarkers of necrotizing enterocolitis in neonates undergoing congenital heart disease surgery: a pilot cohort study. J Am Heart Assoc. 2023;12(15):e030712. doi:10.1161/JAHA.123.030712
7.
FrankBSNandyDKhailovaL, et al.Circulating biomarkers of extracellular matrix dysregulation are associated with adverse post-stage 2 outcomes in infants with single ventricle heart disease. Sci Rep. 2023;13(1):16318. doi:10.1038/s41598-023-43562-4
8.
AlipourSymakani RSvan GenuchtenWJZandbergenLM, et al.The right ventricle in tetralogy of Fallot: adaptation to sequential loading. Front Pediatr. 2023;11:1098248. doi:10.3389/fped.2023.1098248
9.
AvesaniMJalalZFriedbergMK, et al.Adverse remodelling in tetralogy of Fallot: from risk factors to imaging analysis and future perspectives. Hellenic J Cardiol. 2023. doi:10.1016/j.hjc.2023.07.008
10.
ClouthierKLTaylorACXuhuaiJ, et al.A noninvasive circulating signature of combined right ventricular pressure and volume overload in tetralogy of Fallot/pulmonary atresia, and major aortopulmonary collateral arteries. World J Pediatr Congenit Heart Surg. 2023. doi:10.1177/21501351231213626
11.
WeldyCSSyedSAAmsallemM, et al.Circulating whole genome miRNA expression corresponds to progressive right ventricle enlargement and systolic dysfunction in adults with tetralogy of Fallot. PLoS One. 2020;15(11):e0241476. doi:10.1371/journal.pone.0241476
12.
ValdeomillosEJalalZMetrasA, et al.Animal models of repaired tetralogy of fallot: current applications and future perspectives. Can J Cardiol. 2019;35(12):1762-1771.
